Literature DB >> 30637444

Personalized antibiotic dosing for the critically ill.

Jason A Roberts1,2,3,4, Claire Roger5, Jan J De Waele6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30637444     DOI： 10.1007/s00134-019-05522-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

Review 1.  The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.

Authors:  T Tängdén; V Ramos Martín; T W Felton; E I Nielsen; S Marchand; R J Brüggemann; J B Bulitta; M Bassetti; U Theuretzbacher; B T Tsuji; D W Wareham; L E Friberg; J J De Waele; V H Tam; Jason A Roberts
Journal:  Intensive Care Med       Date:  2017-04-13       Impact factor: 17.440

2.  Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.

Authors:  Phillip J Bergen; Jürgen B Bulitta; Carl M J Kirkpatrick; Kate E Rogers; Megan J McGregor; Steven C Wallis; David L Paterson; Roger L Nation; Jeffrey Lipman; Jason A Roberts; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

4.  Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.

Authors:  Gloria Wong; Scott Briscoe; Brett McWhinney; Mumtaz Ally; Jacobus Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  J Antimicrob Chemother       Date:  2018-11-01       Impact factor: 5.790

5.  Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.

Authors:  Giuseppe Valenza; Harald Seifert; Sabine Decker-Burgard; Joerg Laeuffer; Ian Morrissey; Reinier Mutters
Journal:  Int J Antimicrob Agents       Date:  2012-01-09       Impact factor: 5.283

6.  MIC-based dose adjustment: facts and fables.

Authors:  Johan W Mouton; Anouk E Muller; Rafael Canton; Christian G Giske; Gunnar Kahlmeter; John Turnidge
Journal:  J Antimicrob Chemother       Date:  2018-03-01       Impact factor: 5.790

7.  Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.

Authors:  M Beumier; G S Casu; M Hites; F Wolff; F Cotton; J L Vincent; F Jacobs; F S Taccone
Journal:  Minerva Anestesiol       Date:  2014-09-15       Impact factor: 3.051

8.  Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.

Authors:  Emily L Heil; David P Nicolau; Andras Farkas; Jason A Roberts; Kerri A Thom
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 9.  Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Authors:  Jason A Roberts; Mohd H Abdul-Aziz; Jeffrey Lipman; Johan W Mouton; Alexander A Vinks; Timothy W Felton; William W Hope; Andras Farkas; Michael N Neely; Jerome J Schentag; George Drusano; Otto R Frey; Ursula Theuretzbacher; Joseph L Kuti
Journal:  Lancet Infect Dis       Date:  2014-04-24       Impact factor: 25.071

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079
View more
  5 in total

1.  Right Dose, Right Now: Development of AutoKinetics for Real Time Model Informed Precision Antibiotic Dosing Decision Support at the Bedside of Critically Ill Patients.

Authors:  Luca F Roggeveen; Tingjie Guo; Ronald H Driessen; Lucas M Fleuren; Patrick Thoral; Peter H J van der Voort; Armand R J Girbes; Rob J Bosman; Paul Elbers
Journal:  Front Pharmacol       Date:  2020-05-15       Impact factor: 5.810

2.  Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the 'Maximum Tolerable Dose'.

Authors:  Sofie A M Dhaese; Eric A Hoste; Jan J De Waele
Journal:  Antibiotics (Basel)       Date:  2022-07-04

3.  Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients.

Authors:  Jarne Verhaeghe; Sofie A M Dhaese; Thomas De Corte; David Vander Mijnsbrugge; Heleen Aardema; Jan G Zijlstra; Alain G Verstraete; Veronique Stove; Pieter Colin; Femke Ongenae; Jan J De Waele; Sofie Van Hoecke
Journal:  BMC Med Inform Decis Mak       Date:  2022-08-25       Impact factor: 3.298

Review 4.  The Effects of Biological Sex on Sepsis Treatments in Animal Models: A Systematic Review and a Narrative Elaboration on Sex- and Gender-Dependent Differences in Sepsis.

Authors:  MengQi Zhang; Joshua Montroy; Rahul Sharma; Dean A Fergusson; Asher A Mendelson; Kimberly F Macala; Stephane L Bourque; Jared M Schlechte; Mikaela K Eng; Braedon McDonald; Sean E Gill; Kirsten M Fiest; Patricia C Liaw; Alison Fox-Robichaud; Manoj M Lalu
Journal:  Crit Care Explor       Date:  2021-06-14

Review 5.  Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumonia.

Authors:  Shampa Das; Diansong Zhou; Wright W Nichols; Andy Townsend; Paul Newell; Jianguo Li
Journal:  Eur J Clin Pharmacol       Date:  2019-12-14       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.